Page last updated: 2024-08-24

rufloxacin and Benign Neoplasms

rufloxacin has been researched along with Benign Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
D'Antonio, D; Di Marzio, A; Fioritoni, G; Lacone, A; Lombardo, M; Pizzigallo, E; Romano, F; Staniscia, T; Violante, B	1

Trials

1 trial(s) available for rufloxacin and Benign Neoplasms

Article	Year
The impact of rufloxacin given as prophylaxis to patients with cancer on their oral and faecal microflora. The Journal of antimicrobial chemotherapy, 1996, Volume: 38, Issue:5 Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Antibiotic Prophylaxis; Bacteroides; Colony Count, Microbial; Drug Resistance, Microbial; Enterobacteriaceae; Feces; Female; Fluoroquinolones; Humans; Male; Middle Aged; Mouth; Neoplasms; Pilot Projects; Quinolones; Staphylococcus; Streptococcus	1996

Article

Year

The impact of rufloxacin given as prophylaxis to patients with cancer on their oral and faecal microflora.

The Journal of antimicrobial chemotherapy, 1996, Volume: 38, Issue:5

Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Antibiotic Prophylaxis; Bacteroides; Colony Count, Microbial; Drug Resistance, Microbial; Enterobacteriaceae; Feces; Female; Fluoroquinolones; Humans; Male; Middle Aged; Mouth; Neoplasms; Pilot Projects; Quinolones; Staphylococcus; Streptococcus

1996